Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis
about
HIV infection, aging, and immune function: implications for cancer risk and preventionOverview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM developmentSoluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.Tobacco use among adults initiating treatment for HIV infection in rural Uganda.HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts.HIV infection, immunodeficiency, viral replication, and the risk of cancer.Current questions in HIV-associated lung cancer.The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this riskNon-AIDS-defining cancers among HIV-infected patients.Incidence and risk of lung cancer in HIV-infected patients.No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.Combination antiretroviral therapy and cancer risk.Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study.Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico
P2860
Q27004165-A95800D9-0F35-454F-8C5E-429EBD8F8B01Q33564397-10EA6A85-DCED-4D15-B50A-47508062E3C4Q34315579-E64AC2D4-C079-41B7-B609-40BDD9272216Q34411977-C69D8FD5-B80F-43A6-9326-2DE8C4BD07E5Q34957862-89C2F730-2D67-4BE2-9861-4B4A5B095FCAQ35083048-CBA52371-E1CE-4F48-85E7-11ED750F6C87Q35612742-16C6A0D2-7D93-44C4-BE73-2E97CD34CE75Q37529316-266F310F-D8AF-473B-B154-BADC31E94A37Q37600137-9289C81A-D4CF-4E11-8800-591A87880D54Q37712406-7B5D4D42-3AA2-4635-95E4-E880793B6A92Q38112573-F608F29C-D2DE-4075-8707-68FCE2C621B9Q38124683-11EA598D-5A30-4E47-A2DD-0C6A349EC396Q38427594-41706F33-953A-450E-91AA-1B86189B7180Q38984209-62F3CFC0-1E3F-4BA2-8ECB-A1C51032E345Q42282082-BD4445C1-5055-4B68-B20F-4803A9752ACCQ47655423-43D124D6-62D0-46BD-B32E-48B571C15A6FQ58109779-C5D8C853-E232-4CF1-A57D-D2147DE958C4
P2860
Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Incidence of non-AIDS-defining ...... ked randomized trials analysis
@ast
Incidence of non-AIDS-defining ...... ked randomized trials analysis
@en
type
label
Incidence of non-AIDS-defining ...... ked randomized trials analysis
@ast
Incidence of non-AIDS-defining ...... ked randomized trials analysis
@en
prefLabel
Incidence of non-AIDS-defining ...... ked randomized trials analysis
@ast
Incidence of non-AIDS-defining ...... ked randomized trials analysis
@en
P2093
P2860
P356
P1433
P1476
Incidence of non-AIDS-defining ...... ked randomized trials analysis
@en
P2093
ACTG-ALLRT Protocol Team
Ann C Collier
Constance A Benson
Denise L Jacobson
Fred R Sattler
Jeffrey T Schouten
Jorge Santana
Ronald Mitsuyasu
Supriya Krishnan
Susan L Koletar
P2860
P356
10.1159/000328032
P577
2011-05-23T00:00:00Z